Phase 4 Alzheimer's Disease Trial, Recruiting NCT07604896 Sponsor: First Affiliated Hospital of Wenzhou Medical University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 4 Alzheimer's Disease Trial, Recruiting

NCT07604896
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 90 years old.
  • You are any gender.
  • You have been diagnosed with mild cognitive impairment (MCI) or early-stage Alzheimer's disease.
  • Your scores on standard memory and thinking tests fall within a specific range, showing mild but not severe impairment (confirm with trial site).
  • A test (either a brain scan or spinal fluid test) has confirmed the presence of amyloid protein, which is linked to Alzheimer's disease.
  • You have a trusted caregiver who can come with you to appointments and help make sure you take the study medication correctly.
  • You are willing to take part and have signed a consent form agreeing to join the study.

Who may not be able to join:

  • Your memory or thinking problems are caused by something other than Alzheimer's disease.
  • You have had a mini-stroke, stroke, brain bleed, or epileptic seizure in the past 12 months.
  • You have significant depression (based on a standard test), any thoughts of suicide in the past 6 months or at the start of the study, or other mental health conditions such as hallucinations, severe anxiety, or delusions.
  • You have a bleeding disorder, are taking blood-thinning medication, have cancer, or have a serious disease affecting your stomach, kidneys, liver, lungs, immune system, hormones, or heart.
  • You have had an allergic reaction to lecanemab or similar medications (monoclonal antibody treatments).
  • You cannot have an MRI scan, for example because you have a pacemaker or certain metal implants in your body.
  • You have had a known problem with drug or alcohol misuse within the past two years.
  • You have taken part in a clinical trial for an Alzheimer's treatment drug within the past 6 months (unless you can show you were only given a placebo/dummy treatment).
  • You are planning to have surgery under general anaesthetic during the study period.
  • You are pregnant, breastfeeding, or have a positive pregnancy test at the start of the study (applies to women).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8613858868961

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Aβ-PET centiloid values

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov